Dp-ucMGP as a Biomarker in Sarcopenia

Sarcopenia is linked with an increased risk of falls, osteoporosis and mortality and is an increasing problem for healthcare systems. No satisfying biomarkers for sarcopenia diagnosis exist, connecting bone, fat and muscle. Matrix-GLA-protein (MGP) is an adipokine that regulates bone metabolism and is associated with decreased muscle strength. Associations of dp-ucMGP were analyzed in the BioPersMed cohort (58 ± 9 years), including 1022 asymptomatic subjects at moderate cardiovascular risk. Serum measurements of dp-ucMGP in 760 persons were performed with the InaKtif MGP Kit with the IDS-iSYS Multi-Discipline Automated System. DXA data (792 persons) measured with the Lunar iDXA system and physical performance data (786 persons) were available. Dp-ucMGP plasma levels correlate with sarcopenia parameters like gait speed (ρ = −0.192, p < 0.001), appendicular skeletal muscle mass (ρ = 0.102, p = 0.005) and appendicular skeletal muscle mass index (ρ = 0.112, p = 0.001). They are lower in persons with sarcopenia (p < 0.001) and higher in persons with reduced physical performance (p = 0.019). Persons in the lowest dp-ucMGP quartile have the highest risk for reduced muscle mass, decreasing with each quartile, whereas persons in the highest quartile have the highest risk of reduced muscle strength. Dp-ucMGP might be a good biomarker candidate in sarcopenia characterization.

[1]  T. Pieber,et al.  Cohort profile: ‘Biomarkers of Personalised Medicine’ (BioPersMed): a single-centre prospective observational cohort study in Graz/Austria to evaluate novel biomarkers in cardiovascular and metabolic diseases , 2022, BMJ Open.

[2]  OUP accepted manuscript , 2022, American Journal Of Epidemiology.

[3]  T. Pieber,et al.  DXA-Derived Indices in the Characterisation of Sarcopenia , 2021, Nutrients.

[4]  Chiehfeng Chen,et al.  The Optimal Strategy of Vitamin D for Sarcopenia: A Network Meta-Analysis of Randomized Controlled Trials , 2021, Nutrients.

[5]  R. Heshmat,et al.  Patterns of Nutrient Intake in Relation to Sarcopenia and Its Components , 2021, Frontiers in Nutrition.

[6]  J. Ilich.  Osteosarcopenic adiposity syndrome update and the role of associated minerals and vitamins , 2021, Proceedings of the Nutrition Society.

[7]  A. Dolan,et al.  Serum vitamin K1 (phylloquinone) is associated with fracture risk and hip strength in post-menopausal osteoporosis: a cross-sectional study. , 2020, Bone.

[8]  Xu Li,et al.  Matrix Gla protein regulates adipogenesis and is serum marker of visceral adiposity , 2020, Adipocyte.

[9]  Yong Wang,et al.  Matrix Gla Protein Promotes the Bone Formation by Up-Regulating Wnt/β-Catenin Signaling Pathway , 2019, Front. Endocrinol..

[10]  S. Robinson,et al.  Nutrition and Muscle Strength, As the Key Component of Sarcopenia: An Overview of Current Evidence , 2019, Nutrients.

[11]  L. Reynard,et al.  Expression analysis of the osteoarthritis genetic susceptibility mapping to the matrix Gla protein gene MGP , 2019, Arthritis Research & Therapy.

[12]  S. Inoue,et al.  Multiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders , 2019, International journal of molecular sciences.

[13]  Xu Li,et al.  Unexpected Role of Matrix Gla Protein in Osteoclasts: Inhibiting Osteoclast Differentiation and Bone Resorption , 2019, Molecular and Cellular Biology.

[14]  René Rizzoli,et al.  Sarcopenia: revised European consensus on definition and diagnosis , 2018, Age and ageing.

[15]  R. Bokkers,et al.  Quantification of muscle mass in the legs of patients with peripheral arterial occlusive disease: associations between volumetric and cross-sectional single-slice measurements for identification of atrophy and focal sarcopenia. , 2019, The Journal of cardiovascular surgery.

[16]  Y. Ostchega,et al.  Waist Circumference Measurement Methodology Study: National Health and Nutrition Examination Survey, 2016. , 2019, Vital and health statistics. Series 2, Data evaluation and methods research.

[17]  J. Staessen,et al.  Inactive matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans , 2018, Scientific Reports.

[18]  J. Batsis,et al.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies , 2018, Nature Reviews Endocrinology.

[19]  M. Visser,et al.  Vitamin K status and physical decline in older adults-The Longitudinal Aging Study Amsterdam. , 2018, Maturitas.

[20]  S. Akbari,et al.  Vitamin K and Bone Metabolism: A Review of the Latest Evidence in Preclinical Studies , 2018, BioMed research international.

[21]  A. Xiang,et al.  Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis , 2018, Cell Death & Disease.

[22]  H. Hirschfeld,et al.  Osteosarcopenia: where bone, muscle, and fat collide , 2017, Osteoporosis International.

[23]  C. Vermeer,et al.  Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases , 2017, PloS one.

[24]  Richard W. Bohannon,et al.  Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis , 2017, Clinical interventions in aging.

[25]  E. J. Lee,et al.  Matrix gla protein: An extracellular matrix protein regulates myostatin expression in the muscle developmental program , 2017, Life sciences.

[26]  D. Santos,et al.  Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function , 2016, Journal of cachexia, sarcopenia and muscle.

[27]  J. Ilich,et al.  Micronutrient Intake in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity. , 2016, Current aging science.

[28]  S. Booth,et al.  Vitamin K Status and Lower Extremity Function in Older Adults: The Health Aging and Body Composition Study. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  J. Kaufman,et al.  Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. , 2016, Age and ageing.

[30]  J. Staessen,et al.  Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys , 2016, Pulse.

[31]  A. Robling,et al.  Bone and skeletal muscle: Key players in mechanotransduction and potential overlapping mechanisms. , 2015, Bone.

[32]  K. Southward.  A hypothetical role for vitamin K2 in the endocrine and exocrine aspects of dental caries. , 2015, Medical hypotheses.

[33]  J. Reginster,et al.  Sarcopenia: burden and challenges for public health , 2014, Archives of Public Health.

[34]  Zheng Wang,et al.  Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. , 2014, Diabetes research and clinical practice.

[35]  Jeffrey R Stout,et al.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.

[36]  G. Onder,et al.  Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  Ian J. Deary,et al.  Grip Strength across the Life Course: Normative Data from Twelve British Studies , 2014, PloS one.

[38]  S. Nishimoto,et al.  Matrix Gla Protein Binds to Fibronectin and Enhances Cell Attachment and Spreading on Fibronectin , 2014, International journal of cell biology.

[39]  Kozo Nakamura,et al.  Incidence of certified need of care in the long‐term care insurance system and its risk factors in the elderly of Japanese population‐based cohorts: The ROAD study , 2014, Geriatrics & gerontology international.

[40]  Maren S Fragala,et al.  The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[41]  P. Lips,et al.  Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. , 2014, Maturitas.

[42]  J. Pasco,et al.  Total and Appendicular Lean Mass Reference Ranges for Australian Men and Women: The Geelong Osteoporosis Study , 2014, Calcified Tissue International.

[43]  B. Sharma,et al.  Matrix Gla protein reinforces angiogenic resolution. , 2013, Microvascular research.

[44]  C. Mayer,et al.  Using Gene Expression to Predict Differences in the Secretome of Human Omental vs. Subcutaneous Adipose Tissue , 2012, Obesity.

[45]  Luigi Ferrucci,et al.  Sarcopenia with limited mobility: an international consensus. , 2011, Journal of the American Medical Directors Association.

[46]  S. Studenski,et al.  Gait speed and survival in older adults. , 2011, JAMA.

[47]  D. Kuh,et al.  Objectively measured physical capability levels and mortality: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[48]  R. Landewé,et al.  Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species , 2010, Thrombosis and Haemostasis.

[49]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[50]  C. Lewis,et al.  Body Mass Index as a Phenotypic Expression of Adiposity: Quantitative Contribution of Muscularity in a Population-Based Sample , 2009, International Journal of Obesity.

[51]  K. Clément,et al.  Using gene expression to predict the secretome of differentiating human preadipocytes , 2009, International Journal of Obesity.

[52]  L. Ferrucci,et al.  Sarcopenic obesity: definition, cause and consequences , 2008, Current opinion in clinical nutrition and metabolic care.

[53]  L. Schurgers,et al.  Matrix Gla-protein: The calcification inhibitor in need of vitamin K , 2008, Thrombosis and Haemostasis.

[54]  S. Kritchevsky,et al.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[55]  S. Studenski,et al.  Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. , 2006, JAMA.

[56]  K. Boström,et al.  Matrix GLA Protein, a Regulatory Protein for Bone Morphogenetic Protein-2* , 2002, The Journal of Biological Chemistry.

[57]  B. Saltin,et al.  The ageing muscle. , 1983, Clinical physiology.